Neurocrine Biosciences (NBIX) Revenue Growth
Price: $108.155
Market Cap: $10.70B
Avg Volume: 1.61M
Market Cap: $10.70B
Avg Volume: 1.61M
Country: US
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
What is Neurocrine Biosciences's Revenue Growth?
- Neurocrine Biosciences's annual revenue growth as of FY 2024 is 24.81%.
- Neurocrine Biosciences's quarterly revenue growth as of Q4 2024 is 0.90%.
What is Revenue Growth?
Revenue growth is the increase in a company's sales over a specific period. It's a crucial metric for evaluating a company's financial health and its ability to expand its market presence and generate higher sales.
Related Metrics
Other important metrics to assess Neurocrine Biosciences's financial performance include:
- Revenue - the total revenue generated by a company:
- Annual: $2.36B
- Quarterly: $627.70M
- Cost of Revenue - the total cost of producing the goods or services sold by a company:
- Annual: $34.00M
- Quarterly: $9.30M
- Cost of Revenue Growth - the rate at which a company's cost of revenue is growing:
- Annual Growth: -14.36%
- Quarterly Growth: 16.25%
- Gross Profit - the difference between revenue and the cost of revenue:
- Annual: $2.32B
- Quarterly: $618.40M
- Gross Profit Growth - the rate at which a company's gross profit is growing:
- Annual Growth: 25.65%
- Quarterly Growth: 0.70%
These metrics provide insights into Neurocrine Biosciences's financial health and its ability to generate revenue efficiently. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual Revenue Growth
24.81%
Quarterly Revenue Growth
0.90%
Historical Annual Revenue Growth
Historical Quarterly Revenue Growth
Historical Annual Revenue
Historical Quarterly Revenue
Historical Annual Cost of Revenue
Historical Quarterly Cost of Revenue
Historical Annual Gross Profit
Historical Quarterly Gross Profit
Neurocrine Biosciences Historical Revenue Growth Metrics
The table below shows various financial metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Revenue | Revenue Growth | Cost of Revenue | Cost of Revenue Growth | Gross Profit | Gross Profit Growth |
|---|---|---|---|---|---|---|
| 2024 | $2.36B | 24.81% | $34.00M | -14.36% | $2.32B | 25.65% |
| 2023 | $1.89B | 26.76% | $39.70M | 71.12% | $1.85B | 26.06% |
| 2022 | $1.49B | 31.34% | $23.20M | 62.24% | $1.47B | 30.94% |
| 2021 | $1.13B | 8.38% | $14.30M | 41.58% | $1.12B | 8.05% |
| 2020 | $1.05B | 32.71% | $10.10M | 36.49% | $1.04B | 32.68% |
| 2019 | $788.10M | 74.65% | $7.40M | 51.36% | $780.70M | 74.91% |
| 2018 | $451.24M | 179.19% | $4.89M | 289.87% | $446.35M | 178.32% |
| 2017 | $161.63M | 977.51% | $1.25M | -96.51% | $160.37M | 867.33% |
| 2016 | $15.00M | -24.12% | $35.90M | 6.21% | $-20.90M | -48.96% |
| 2015 | $19.77M | 0.00% | $33.80M | 134.72% | $-14.03M | 2.56% |
Related Metrics
Explore detailed financial metrics and analysis for NBIX.